- Home
- EDBL vs ATNF Comparison
EDBL vs ATNF Comparison
Compare EDBL & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- ATNF
- Stock Information
- Founded
- EDBL 2020
- ATNF 2016
- Country
- EDBL United States
- ATNF United States
- Employees
- EDBL N/A
- ATNF N/A
- Industry
- EDBL Farming/Seeds/Milling
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- ATNF Health Care
- Exchange
- EDBL Nasdaq
- ATNF Nasdaq
- Market Cap
- EDBL 3.0M
- ATNF 2.6M
- IPO Year
- EDBL 2022
- ATNF N/A
- Fundamental
- Price
- EDBL $0.14
- ATNF $1.74
- Analyst Decision
- EDBL
- ATNF
- Analyst Count
- EDBL 0
- ATNF 0
- Target Price
- EDBL N/A
- ATNF N/A
- AVG Volume (30 Days)
- EDBL 1.2M
- ATNF 128.8K
- Earning Date
- EDBL 11-13-2024
- ATNF 02-13-2025
- Dividend Yield
- EDBL N/A
- ATNF N/A
- EPS Growth
- EDBL N/A
- ATNF N/A
- EPS
- EDBL N/A
- ATNF N/A
- Revenue
- EDBL $14,069,000.00
- ATNF N/A
- Revenue This Year
- EDBL $2.43
- ATNF N/A
- Revenue Next Year
- EDBL $42.42
- ATNF $54.15
- P/E Ratio
- EDBL N/A
- ATNF N/A
- Revenue Growth
- EDBL 7.88
- ATNF N/A
- 52 Week Low
- EDBL $0.12
- ATNF $1.16
- 52 Week High
- EDBL $12.47
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- EDBL 33.42
- ATNF 32.45
- Support Level
- EDBL $0.14
- ATNF $1.69
- Resistance Level
- EDBL $0.18
- ATNF $2.26
- Average True Range (ATR)
- EDBL 0.02
- ATNF 0.19
- MACD
- EDBL 0.00
- ATNF -0.02
- Stochastic Oscillator
- EDBL 4.67
- ATNF 4.61
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses, together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.